DONATE NOW

Daily Archives: February 15, 2019

CMS unveils CAR-T proposal, with emphasis on patient outcomes

“Two CAR-T therapies — Novartis’ Kymriah (tisagenlecleucel) and Gilead Sciences’ Yescarta (axicabtagene ciloleucel) — are already on the market, yet their high price tags and potentially one-time administration has put pressure on CMS to figure out a way to cover these kinds of treatments. The agency took a few steps toward that goal over the